Status:
COMPLETED
Self-efficacy, Beliefs and Adherence- Pilot and Feasibility Trial of a Pharmacist-led Intervention
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
Merck Sharp & Dohme LLC
William S. Middleton Memorial Veterans Hospital
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This study uses an intervention mixed methods design. The overall purpose is to improve medication adherence and assess the clinical impact on diabetes outcomes among patients with uncontrolled diabet...
Detailed Description
The study will improve medication adherence for patients with diabetes using two strategies: 1) addressing health literacy by reducing the complexity of diabetes content disseminated to patients durin...
Eligibility Criteria
Inclusion
- English-speaking men and women 18-80 years old with diabetes
- Taking oral diabetes medications and/or insulin
- One hemoglobin A1C measure of 8% or greater in the last 18 months
- A score less than 25 on the Medication Adherence Rating Scale (MARS-5)
Exclusion
- Unable to provide informed consent
- Younger than 18 years old or older than 80 years old
- Unable to understand English
- Do not take oral diabetes medications and/or insulin
- A score equal to 25 on the Medication Adherence Rating Scale (MARS-5)
Key Trial Info
Start Date :
December 4 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT03406923
Start Date
December 4 2018
End Date
December 31 2020
Last Update
February 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
William S. Middleton Memorial Veterans Hospital
Madison, Wisconsin, United States, 53705